S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

KROS Keros Therapeutics Inc

11.76

-0.26 (-2.16%)

25 Jan 2025 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Keros Therapeutics (NASDAQ:KROS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Keros Therapeutics Charts.

Keros Therapeutics (NASDAQ:KROS)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Keros Therapeutics Charts.

Keros Therapeutics Inc News

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Saturday 25 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 22 January 2025 (6 days ago) • Edgar (US Regulatory)

Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept
Wednesday 22 January 2025 (6 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 15 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial
Wednesday 15 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 11 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (2 months ago) • Edgar (US Regulatory)

Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial
Thursday 12 December 2024 (2 months ago) • GlobeNewswire Inc.

Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition
Tuesday 10 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 3 December 2024 (2 months ago) • Edgar (US Regulatory)

Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept
Tuesday 3 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

More Keros Therapeutics Inc News Articles

Verizon Communications

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions